ProductsBack/ELISA Kit for Angiopoietin Like Protein 2 (ANGPTL2)

ELISA Kit for Angiopoietin Like Protein 2 (ANGPTL2)

Name: ELISA Kit for Angiopoietin Like Protein 2 (ANGPTL2)
SKU: SEB919HU_U80
Availability: BackOrder

SEB919HU

Product group Assays

Overview

Supplier
Cloud-Clone Corp.
Product Name
ELISA Kit for Angiopoietin Like Protein 2 (ANGPTL2)
Delivery Days Customer
12
Assay Detection Range
0.312-20ng/mL
Assay Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Angiopoietin Like Protein 2 (ANGPTL2) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, ...
Assay Sensitivity
The minimum detectable dose of this kit is typically less than 0.125ng/mL
Assay Specificity
This assay has high sensitivity and excellent specificity for detection of Angiopoietin Like Protein 2 (ANGPTL2). No significant cross-reactivity or interference between Angiopoietin Like Protein 2 (ANGPTL2) and analogues was observed.
Assay Test Principle
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Angiopoietin Like Protein 2 (ANGPTL2). Standards or samples are then added to the ...
Assay Time
3h
Certification
Research Use Only
UNSPSC
41116158

Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes. Schneider F et al., 2018 Jun 8, Cardiovasc Diabetol
Read more
ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients. Gellen B et al., 2016 Nov, Diabetologia
Read more
Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients. Toiyama Y et al., 2015 Dec, Carcinogenesis
Read more
Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence. Toiyama Y et al., 2014 Dec 1, Clin Cancer Res
Read more